. . . But The Figures Can Exaggerate Our Anxiety

Although Richard Atkinson makes an eloquent appeal for increasing the flow of individuals into science and engineering, his basic argument is flawed. He states that "a fortuitous coincidence between an available college-age population and an expanding financial base for science and technology" combined to fuel the three major surges in college enrollments, and in turn, the production of scientists and engineers during this century. Isn't it interesting that this growth and interest in science i

Written byMorton Lefar
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Although Richard Atkinson makes an eloquent appeal for increasing the flow of individuals into science and engineering, his basic argument is flawed. He states that "a fortuitous coincidence between an available college-age population and an expanding financial base for science and technology" combined to fuel the three major surges in college enrollments, and in turn, the production of scientists and engineers during this century. Isn't it interesting that this growth and interest in science is "fortuitous," yet later on in his analysis, statistics are used to "predict" supply and demand to the year 2010!

Was it a coincidence that over the last five years - a period in which the stock market reached new highs - there was a huge surge in the number of graduate students in business administration and finance programs? I would argue that chance played no role in this increase. Rather, there was a clear recognition ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies